Atwood & Palmer’s Trinity Biotech TRIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | – | Sell |
-1
| Closed | -$8 | – | 516 |
|
|
2026
Q2 | $8 | Hold |
1
| – | – | ﹤0.01% | 493 |
|
|
2026
Q1 | $11 | Hold |
1
| – | – | ﹤0.01% | 528 |
|
|
2025
Q4 | $16 | Hold |
1
| – | – | ﹤0.01% | 483 |
|
|
2025
Q3 | $21 | Hold |
1
| – | – | ﹤0.01% | 482 |
|
|
2025
Q2 | $13 | Hold |
1
| – | – | ﹤0.01% | 509 |
|
|
2025
Q1 | $12 | Hold |
1
| – | – | ﹤0.01% | 437 |
|
|
2024
Q4 | $18 | Hold |
1
| – | – | ﹤0.01% | 466 |
|
|
2024
Q3 | $22 | Hold |
1
| – | – | ﹤0.01% | 469 |
|
|
2024
Q2 | $43 | Hold |
1
| – | – | ﹤0.01% | 432 |
|
|
2024
Q1 | $41 | Hold |
1
| – | – | ﹤0.01% | 410 |
|
|
2023
Q4 | $43 | Hold |
1
| – | – | ﹤0.01% | 398 |
|
|
2023
Q3 | $74 | Hold |
1
| – | – | ﹤0.01% | 411 |
|
|
2023
Q2 | $96 | Hold |
1
| – | – | ﹤0.01% | 391 |
|
|
2023
Q1 | $94 | Hold |
1
| – | – | ﹤0.01% | 365 |
|
|
2022
Q4 | $99 | Hold |
1
| – | – | ﹤0.01% | 385 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 403 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 445 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 466 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 463 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 442 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 449 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 453 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 386 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 345 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 329 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 325 |
|
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 303 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 315 |
|
|
2019
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 332 |
|
|
2019
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 336 |
|
|
2018
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 334 |
|
|
2018
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 332 |
|
|
2018
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 307 |
|
|
2018
Q1 | $1K | Hold |
1
| – | – | ﹤0.01% | 288 |
|
|
2017
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 285 |
|
|
2017
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 294 |
|
|
2017
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 314 |
|
|
2017
Q1 | $1K | Hold |
1
| – | – | ﹤0.01% | 293 |
|
|
2016
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 328 |
|
|
2016
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 319 |
|
|
2016
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 302 |
|
|
2016
Q1 | $1K | Hold |
1
| – | – | ﹤0.01% | 308 |
|
|
2015
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 393 |
|
|
2015
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 425 |
|
|
2015
Q2 | $2K | Hold |
1
| – | – | ﹤0.01% | 356 |
|
|
2015
Q1 | $2K | Hold |
1
| – | – | ﹤0.01% | 312 |
|
|
2014
Q4 | $2K | Hold |
1
| – | – | ﹤0.01% | 366 |
|
|
2014
Q3 | $2K | Hold |
1
| – | – | ﹤0.01% | 366 |
|
|
2014
Q2 | $2K | Buy |
+1
| New | +$3.56K | ﹤0.01% | 317 |
|
Atwood & Palmer's TRIB Position: Q3 2026 in Review
Atwood & Palmer sold out of Trinity Biotech (TRIB) in Q3 2026, closing a stake of 1 share — an estimated $8 sold.
Atwood & Palmer first reported a position in TRIB in Q2 2014 and held it in 49 quarters. The position peaked at $2K in Q2 2015. 0 funds tracked by Wall St. Rank hold TRIB as of Q3 2026.
- Atwood & Palmer reported no remaining Trinity Biotech position as of Q3 2026 after selling out during the quarter.
- Atwood & Palmer sold 1 Trinity Biotech share in Q3 2026, an estimated $8.
- Atwood & Palmer first reported a position in Trinity Biotech in Q2 2014 and held it in 49 quarters.
- Atwood & Palmer's Trinity Biotech position peaked at $2K in Q2 2015.
- 0 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2026.
Based on Atwood & Palmer's 13F filing for Q3 2026, filed 8 Oct 2026.